$36.0M
The financing will support manufacturing expansion and commercial launch preparation ahead of clinical trials.
S
Sava
Sava develops miniature microsensors designed to replace traditional fingerstick glucose monitoring.
London, UK—Founded 2019
$63.0MTotal raised
Sava is a London-based medical technology company developing miniature sensors designed to eliminate the need for traditional fingerstick glucose testing for people with diabetes.
Categories
Founders
Rafaël Michali
Investors
- $36.0M
- $19.0M
- $8.0M
Funding history
$19.0M
The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
$8.0M
The London startup will use the capital to expand its team, develop next-generation products, and demonstrate clinical performance.